GlassScriptPhysician profile
Stuart Y Tsuji
NPI 1558534602
$774.03
in general payments reported to CMS, 2019-2025
13 companies · $262 in 2025
The $262 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.15 · 2021: $66.60 · 2022: $61.86 · 2023: $47.66 · 2024: $248 · 2025: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $557.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Icotec Medical INC. | $146.30 | 2022-2024 | Vader Pedicle System |
| Novartis Pharmaceuticals Corporation | $134.08 | 2024-2025 | |
| Pfizer INC. | $78.07 | 2021-2024 | |
| Varian Medical Systems, INC. | $68.93 | 2019 | |
| Teleflex LLC | $60.03 | 2024-2025 | Barrigel |
| Sumitomo Pharma America, INC. | $59.50 | 2024-2025 | Orgovyx |
| Astrazeneca Pharmaceuticals LP | $57.86 | 2024-2025 | Imfinzi |
| Janssen Biotech, INC. | $49.64 | 2023-2025 | Erleada, Darzalex, Tecvayli |
| Siemens Medical Solutions USA, INC. | $36.52 | 2025 | Truebeam |
| Elekta, INC. | $28.69 | 2019-2021 | |
| Novocure INC. | $21.73 | 2025 | Optune Gio |
| E.R. Squibb & Sons, L.L.C. | $18.69 | 2024 | Opdivo |
| Monteris Medical Corporation | $13.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Tsuji listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.